Shared compound evidence record
Tesamorelin (20mg)
Weight Management
In Stock
Tesamorelin
10mg Lyophilised Powder
$119.99AUD per vial
1
1 vial · Item total$119.99 AUD
Free express shipping Australia-wide
No account needed. PayID or bank transfer instructions follow checkout.
Labelled quantity
10mg
Category
Weight Management
Volume Savings
Availability
Ready to purchase now
In stock now and ready for checkout.
Next business day dispatch cutoff
Order within the current dispatch window
Melbourne cut-off time updates live every second.
Time Remaining
15:33:00
Associated report summary: 99.796% purity reported
Catalogue-associated report; current inventory-lot match not established.
Frequently Bought Together
Stable research navigation
Connected catalogue records
These links are based on catalogue family, evidence records, research topics and bundle composition. They do not imply therapeutic similarity.
Connected compound evidence
CJC-1295 (no DAC) (10mg)
Performance & Recovery
Connected compound evidence
CJC-1295 (no DAC) + Ipamorelin (10mg)
Performance & Recovery
Connected compound evidence
Tirzepatide (20mg)
Weight Management
Connected compound evidence
CJC-1295 with DAC (10mg)
Performance & Recovery
Connected compound evidence
Tirzepatide (40mg)
Weight Management
Research library
Evidence and analytical context for this record
These resources separate compound identity, batch-quality questions and study evidence. A linked study does not establish that this catalogue material is equivalent to a medicine or investigational product.
Product Information
Tesamorelin (10mg) — GHRH and Body-Composition Research
Tesamorelin is a stabilised synthetic analogue of growth hormone-releasing hormone (GHRH). It is used in controlled research examining GHRH receptor activation and the downstream growth hormone and IGF-1 signalling axis, with particular interest in adipose-tissue and body-composition models.
Key Research Areas
- GHRH Receptor Activity — Investigation of receptor binding and endogenous growth-hormone signalling
- GH/IGF-1 Axis — Study of downstream endocrine and metabolic responses
- Visceral Adipose Biology — Research focused on deep abdominal adipose-tissue dynamics
- Lipid Metabolism — Investigation of triglyceride handling and related metabolic markers
- Body-Composition Models — Analysis of fat distribution and lean-tissue signalling pathways
Supplied as a nominal 10mg lyophilised powder. The current documented batch is reported at 99.796% purity, with batch-specific analytical information available in our CoA Library and fast domestic shipping across Australia.
For in-vitro research and laboratory use only. Not for human or veterinary use or consumption.
Frequently Asked Questions
What is Tesamorelin (10mg)?
Tesamorelin (10mg) is a stabilised GHRH analogue supplied for controlled studies of GHRH receptor activity, downstream GH/IGF-1 signalling, visceral adipose biology and body-composition pathways.
How is the 10mg format different from 5mg and 20mg?
The compound is the same across the catalogue's Tesamorelin formats; only the nominal vial quantity changes. The 10mg listing sits between the smaller 5mg and larger 20mg research formats.
How do you reconstitute Tesamorelin?
Tesamorelin is supplied as a lyophilised powder and should be prepared with an appropriate laboratory-grade solvent under controlled research conditions. Follow the study protocol, batch documentation and institutional handling requirements.
Where to buy Tesamorelin 10mg in Australia?
Tesamorelin (10mg) is listed by AUS Peptide Supply with domestic shipping to all Australian states and territories. Current availability is shown live on this page, with batch-specific documentation in our CoA Library.
What is the availability and cost of Tesamorelin 10mg?
Tesamorelin (10mg) is currently in stock at AUS Peptide Supply and available for domestic dispatch across Australia. Tesamorelin (10mg) is priced at $119.99 AUD per vial at AUS Peptide Supply. Check this page's analytical-document status and the CoA library for published records.